BPTRX
Price
$205.07
Change
-$6.17 (-2.92%)
Updated
Nov 13 closing price
Net Assets
7.69B
RGEBX
Price
$83.30
Change
-$1.87 (-2.20%)
Updated
Nov 13 closing price
Net Assets
340.4B
Interact to see
Advertisement

BPTRX vs RGEBX

Header iconBPTRX vs RGEBX Comparison
Open Charts BPTRX vs RGEBXBanner chart's image
Baron Partners Retail
Price$205.07
Change-$6.17 (-2.92%)
VolumeN/A
Net Assets7.69B
American Funds Growth Fund of Amer R2E
Price$83.30
Change-$1.87 (-2.20%)
VolumeN/A
Net Assets340.4B
BPTRX vs RGEBX Comparison Chart in %
View a ticker or compare two or three
VS
BPTRX vs. RGEBX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BPTRX is a Hold and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 340B vs. BPTRX (7.69B). BPTRX (0.00) and RGEBX (0.00) have matching dividends . BPTRX was incepted earlier than RGEBX: BPTRX (23 years) vs RGEBX (11 years). BPTRX (2.24) is less costly to investors than RGEBX (1.09). RGEBX is a more actively managed with annual turnover of: 25.00 vs. BPTRX (1.00). RGEBX has a lower initial minimum investment than BPTRX: RGEBX (250) vs BPTRX (2000). BPTRX annual gain was more profitable for investors over the last year : 11.07 vs. RGEBX (8.10). BPTRX return over 5 years is better than : 62.70 vs. RGEBX (36.65).
BPTRXRGEBXBPTRX / RGEBX
Total Expense Ratio2.241.09206%
Annual Report Gross Expense Ratio2.241.09206%
Fund Existence23 years11 years-
Gain YTD-2.54119.219-13%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets7.69B340B2%
Annual Yield % from dividends0.000.00-
Returns for 1 year11.078.10137%
Returns for 3 years55.6262.3989%
Returns for 5 years62.7036.65171%
Returns for 10 years494.2493.78527%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DRUG60.150.91
+1.54%
Bright Minds Biosciences
SRPT18.000.02
+0.11%
Sarepta Therapeutics
WSBCP24.98N/A
N/A
WesBanco
XP19.21-0.59
-2.98%
XP
HKIT2.37-0.39
-14.13%
Hitek Global